Lataa...
Long-term Follow-up of Psilocybin-facilitated Smoking Cessation
BACKGROUND: A recent open-label pilot study (N=15) found that two to three moderate to high doses (20 and 30 mg/70 kg) of the serotonin 2A receptor agonist psilocybin, in combination with cognitive behavioral therapy (CBT) for smoking cessation, resulted in substantially higher 6-month smoking absti...
Tallennettuna:
| Julkaisussa: | Am J Drug Alcohol Abuse |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5641975/ https://ncbi.nlm.nih.gov/pubmed/27441452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/00952990.2016.1170135 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|